ThompsonAJBaranziniSEGeurtsJ, et al. Multiple sclerosis. Lancet2018; 391: 1622–1636.
2.
FitzgeraldKCSalterATyryT, et al. Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis. Mult Scler. Epub ahead of print 13 May 2019. DOI: 10.1177/1352458519845836.
3.
FilippatouALambeJSotirchosE, et al. Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis. Mult Scler2020; 26(7): 843–854.
4.
ZareiRAnvariPEslamiY, et al. Retinal nerve fibre layer thickness is reduced in metabolic syndrome. Diabet Med2017; 34: 1061–1066.
5.
YiYHChoYHKimYJ, et al. Metabolic syndrome as a risk factor for high intraocular pressure: The Korea National Health and Nutrition Examination Survey 2008–2010. Diabetes Metab Syndr Obes2019; 12: 131–137.
6.
LeeITWangJSFuCP, et al. The synergistic effect of inflammation and metabolic syndrome on intraocular pressure: A cross-sectional study. Medicine2017; 96(36): e7851.
7.
BlochEYonova-DoingEJones-OdehE, et al. Genetic and environmental factors associated with the ganglion cell complex in a healthy aging British cohort. JAMA Ophthalmol2017; 135: 31–38.
8.
KhawajaAPChuaSHysiPG, et al. Comparison of associations with different macular inner retinal thickness parameters in a large cohort: The UK Biobank. Ophthalmology2020; 127: 62–71.
9.
GordonMOKassMA.The ocular hypertension treatment study design and baseline description of the participants. Arch Ophthalmol1999; 117(5): 573–583.
10.
BerdahlJPFleischmanDZaydlarovaJ, et al. Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci2012; 53: 1422–1427.
